Travere Therapeutics, Inc. · NASDAQ:TVTX
Rote William E. sold 2,763 Travere Therapeutics, Inc. shares (Form 4)
Traded May 4 to May 6, 2026 · Filed May 6, 2026
From May 4 to May 6, 2026, Rote William E. (Chief Research Officer) sold 2,763 Travere Therapeutics, Inc. shares at US$43.95 for US$121K under a trading plan, leaving 115,474 shares. Filed May 6, 2026 (Form 4).
- Sold
- 2,763 shares
- Price
- US$43.95
- Value
- US$121K
- Holding after
- 115,474 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Research Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 4, 2026 | Common Stock | Option exercise | 4,250 | 118,237 | Direct | |
| May 6, 2026 | Common Stock | Sale | 2,763 | US$43.95 | 115,474 | Direct |
Source
Related
- Travere Therapeutics, Inc.
- Rote William E.
- Travere Therapeutics, Inc. shareholders
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Rote William E. · Apr 23, 2026
- Form 4 · Rote William E. · Apr 15, 2026
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026